This module provides an expert brief on the increasing recognition of Lipoprotein(a) [Lp(a)] as a significant, independent risk factor for cardiovascular disease in Canada, and its implications for risk assessment and management.
The Role of Lp(a) in Canadian CVD Risk Assessment
CAN-eng
$0
free
Unaccredited
5 min
Cardiology
0 Credits
Course Description
Course Details
Expiry Date: 2026-09-27
Professions: Physician
Faculty
Accreditation
Learning Objective(s)
After viewing this microlearning, participants will be better able to:
- Explain the clinical significance of lipoprotein(a) [Lp(a)] in cardiovascular risk assessment and management.